- Filed
- May 14, 2025 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q3 2025 · May 8, 2025 | 11.71M sh |
| Stock Repurchased | Q3 2025 · Mar 31, 2025 | $1.5M |
| Short Term Debt | Q3 2025 · Mar 31, 2025 | $18.98K |
| Cash And Equivalents | Q3 2025 · Mar 31, 2025 | $18.77M |
| Cash And Equivalents | Q3 2025 · Jun 30, 2024 | $19.13M |
| Stockholders Equity | Q3 2025 · Mar 31, 2025 | $35.45M |
| Stockholders Equity | Q3 2025 · Jun 30, 2024 | $34.84M |
| Current Liabilities | Q3 2025 · Mar 31, 2025 | $18.74M |
| Current Liabilities | Q3 2025 · Jun 30, 2024 | $23.87M |
| Total Liabilities | Q3 2025 · Mar 31, 2025 | $19.25M |
| Total Liabilities | Q3 2025 · Jun 30, 2024 | $24.65M |
| Current Assets | Q3 2025 · Mar 31, 2025 | $42.41M |
| Current Assets | Q3 2025 · Jun 30, 2024 | $47.46M |
| Total Assets | Q3 2025 · Mar 31, 2025 | $58.14M |
| Total Assets | Q3 2025 · Jun 30, 2024 | $64.19M |
| Shares Diluted | Q3 2025 · Mar 31, 2024 | 11.43M sh |
| Shares Diluted | Q3 2025 · Mar 31, 2024 | 11.41M sh |
| Capex | Q3 2025 · Mar 31, 2024 | $948.34K |
| Operating Cash Flow | Q3 2025 · Mar 31, 2024 | −$3.6M |
| Eps Diluted | Q3 2025 · Mar 31, 2024 | $0.03 |
| Eps Diluted | Q3 2025 · Mar 31, 2024 | $0.07 |
| Eps Basic | Q3 2025 · Mar 31, 2024 | $0.03 |
| Eps Basic | Q3 2025 · Mar 31, 2024 | $0.07 |
| Rd Expense | Q3 2025 · Mar 31, 2024 | $345.58K |
| Rd Expense | Q3 2025 · Mar 31, 2024 | $1.07M |
| Net Income | Q3 2025 · Mar 31, 2024 | $327.55K |
| Net Income | Q3 2025 · Mar 31, 2024 | $766.76K |
| Operating Income | Q3 2025 · Mar 31, 2024 | $1.32M |
| Operating Income | Q3 2025 · Mar 31, 2024 | $2.7M |
| Gross Profit | Q3 2025 · Mar 31, 2024 | $7.47M |
| Gross Profit | Q3 2025 · Mar 31, 2024 | $20.81M |
| Cost Of Revenue | Q3 2025 · Mar 31, 2024 | $7.99M |
| Cost Of Revenue | Q3 2025 · Mar 31, 2024 | $24.13M |
| Revenue | Q3 2025 · Mar 31, 2024 | $15.46M |
| Revenue | Q3 2025 · Mar 31, 2024 | $44.94M |